Hemostatic Agent Therapy

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/18

encourage image

There's no tags or description

Looks like no tags are added yet.

19 Terms

1
New cards

Desmopressin

Used in mild hemophilia A + von Willebrand disease (type 1)

MOA:

  • Stimulates V2 receptors —> triggers release of vWF and factor VIII —> increases clot formation

ADR:

  • hyponatremia: monitor sodium!!

*pt can not take with aspirin

*limit free water

2
New cards

Tranexamic Acid (TXA)


Used for bleedingafter trauma, surgery, postpartum hemorrhage

MOA:

  • blocks plasminogen binding to fibrin —> prevents dissolution of clot

ADR:

  • seizures

  • hypotension

*monitor for DVT/PE

3
New cards

Aminocaproic Acid

Antifibrinolytic

Used for hemophilia-related bleeding, surgical bleeding

MOA:

  • inhibits plasminogen activation —> decreases plasmin —> decreases fibrin breakdown

ADR:

  • hypotension (administer slowly via IV!!)

*monitor for DVT/PE

4
New cards

Hemostatic Agent Therapy Overview

DDAVP (desmopressin) promotes clot formation

Antifibrinolytics prevent clot breakdown

5
New cards

Antithrombotic Therapy Overview

Prevent or treat harmful blood clot formation

  • antiplatelets

  • anticoagulants

  • thrombolytics

* Nobody on anticoagulants can take NSAIDs

6
New cards

Cox-1 Inhibitors Prototype

Aspirin

7
New cards

Aspirin

MOA:

  • Inhibits COX-1 —> lowers platelet activation and aggregation

  • wors on intrinsic pathways

ADR:

  • bleeding

*do not give to children under 18 w/ viral illness = Reye’s syndrome


8
New cards

P2Y12 receptor inhibitors prototype

clopidogrel

  • often used with aspirin


9
New cards

Clopidogrel

MOA:

  • blocks P2Y12 receptors —> lowers platelet activation and aggregation

ADR:

  • bleeding/ hemorrhage

Black box warning: reduced effectiveness in CYP2C19 poor metabolizers

10
New cards

GP 11b/111a Inhibitors prototype: Eptifibatide


Used in ACS/ other coronary interventions

MOA:

  • blocks GP IIb/ IIIa receptors (final step of aggregation)

ADR:

  • severe bleeding


11
New cards

Unfractionated Heparin

MOA:

  • inhibits factor Xa and thrombin

ADR:

  • bleeding

  • HIT

*antidote = protamine sulfate

BLACK BOX: spinal/ epidural bleeding = paralysis

12
New cards

Low-molecular-weight heparin: Enoxaparin

MOA:

  • mainly inhibits factor Xa

ADR

  • bleeding/ HIT

*Protamine sulfate is not as effective for reversal

* Rotate injection sites

BLACK BOX: spinal/ epidural bleeding = paralysis

13
New cards

Heparin-Induced Thrombocytopenia (HIT)

Immune reaction to heparin = increases blood clots

  • antibodies form against heparin

  • around 50% decrease of platelets

  • usually occurs 5-10 days after starting heparin

S/S:

  • new DVT/ PE


14
New cards

Vit K antagonist: Warfarin

MOA:

  • blocks vitamin K recycling —> decreases production of clotting factors

  • works on the extrinsic pathways

ADR:

  • bleeding/ hemorrhage

BLACK BOX: major/ fatal bleeding

*monitor INR (usually 2-3)

*maintain consistent vitamin K (leafy greens)

*antidote = vitamin K


15
New cards

Direct Oral Anticoagulants

  • factor Xa inhibitors

  • direct thrombin inhibitors


16
New cards

Factor Xa Inhibitors: apixaban

MOA:

  • blocks factor Xa —> decreases thrombin

*antidote: 4-factor PCC


17
New cards

Thrombin Inhibitors: dabigatran

MOA:

  • Blocks thrombin —> decreases fibrin

*antidote = idarcizumab


18
New cards

Thrombolytics (Fibrinolytics) Prototype

Prototype: alteplase

  • similar: Tenecteplase



19
New cards

Alteplase

Used for acute ischemic stroke, PE, or MI

MOA:

  • converts plasminogen —> dissolves existing clots

ADR:

  • severe bleeding

  • intracranial hemorrhage

*do not give to people who are stable